Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GALSULFASE vs GANCICLOVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GALSULFASE vs GANCICLOVIR: Safety Overview

Metric GALSULFASE GANCICLOVIR
Total FAERS Reports 2,809 4,990
Deaths Reported 238 1,469
Death Rate 8.5% 29.4%
Hospitalizations 1,007 1,735
Average Patient Age 16.3 yrs 41.7 yrs
% Female Patients 53.7% 41.5%
FDA Approval Date N/A Dec 12, 1997
Manufacturer BioMarin Pharmaceutical Inc. Pharmascience Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Discontinued